HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings38 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
PDDPDD
ADR

PDD HOLDINGS INC

4.2M$425.6M25.4%$114.13-11.76%
16 qtrssince 2022-Q2
Decreased
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

2.5M$307.8M18.4%$144.74-14.11%
16 qtrssince 2022-Q2
Decreased
0
ONCONC
ADR

BEIGENE LTD-ADR

1M$307.2M18.4%$134.02+170.48%
30 qtrssince 2018-Q4
Unchanged
0
FUTUFUTU
ADR

FUTU HLDGS LTD

1.4M$194.1M11.6%$95.17+52.05%
8 qtrssince 2024-Q2
Decreased
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

6M$108.3M6.5%$50.33-64.51%
24 qtrssince 2020-Q2
Unchanged
0

ARRIVENT BIOPHARMA INC

3.9M$90.6M5.4%$17.95+33.40%
9 qtrssince 2024-Q1
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

4.2M$63.4M3.8%$21.74-23.72%
23 qtrssince 2020-Q3
Unchanged
0
CWANCWANDelisted

CLEARWATER ANALYTICS HDS-A

1.4M$32.3M1.9%$22.00
4 qtrssince 2025-Q2
Unchanged
0

CYTEK BIOSCIENCES INC

6.7M$29.1M1.7%$20.96-78.82%
19 qtrssince 2021-Q3
Unchanged
0

MARVELL TECHNOLOGY INC

171,033$16.9M1.0%$77.510.00%
1 qtr
New
65
YSYSG
ADR

YATSEN HLDG LTD

4.9M$15M0.9%$10.59-64.31%
22 qtrssince 2020-Q4
Unchanged
0
NBPNBP
ADR

NOVABRIDGE BIOSCIENCES

6M$14.7M0.9%$47.24-93.23%
23 qtrssince 2020-Q3
Unchanged
0

MAZE THERAPEUTICS INC

366,028$10.9M0.7%$11.42+286.87%
5 qtrssince 2025-Q1
Decreased
0

CONTINEUM THERAPEUTICS INC

669,337$8.7M0.5%$17.61-19.93%
8 qtrssince 2024-Q2
Unchanged
0
APIAPI
ADR

AGORA INC

2.1M$7.4M0.4%$4.20+8.57%
6 qtrssince 2024-Q4
Unchanged
0

WEBULL CORP

1.5M$7.2M0.4%$10.83-44.97%
4 qtrssince 2025-Q2
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

15,520$5.2M0.3%$314.14+12.41%
2 qtrssince 2025-Q4
Increased
43

SAGIMET BIOSCIENCES INC

724,800$3.8M0.2%$8.80-36.14%
11 qtrssince 2023-Q3
Unchanged
0
TUYATUYA
ADR

TUYA INC

1.6M$3.6M0.2%$19.21-86.99%
21 qtrssince 2021-Q1
Unchanged
0

GENERAL ELECTRIC CO COM STOCK

10,043$2.8M0.2%$204.11+63.71%
9 qtrssince 2024-Q1
Unchanged
0
$1.7B
AUM
38
Positions
Q1 2026
Filing
Rating · 2.0
Quarterly Portfolio Change
-37%Q4'24$2.9B+23%Q1'25$3.5B-12%Q2'25$3.1B+32%Q3'25$4.1B-24%Q4'25$3.1B-46%Q1'26$1.7B
Activity profile
$ moved · Q1'26
New2%Increased0%Decreased98%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.4 years
<1Q16%1-4Q16%1-2Y5%2Y+63%

HHLR ADVISORS, LTD. manages $1.7B across 38 positions as of Q1 2026. Top holdings: PDD (25.4%), BABA (18.4%), ONC (18.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q1 2026 Summary

Active quarter - 9 new positions, 4 exits, 2 increased. Top move: MRVL (NEW, conviction 65). Portfolio: $1.7B across 38 positions.

Top holdings by portfolio weight

Total AUM$2B
PDD25.44%
BABA18.40%
ONC18.36%
FUTU11.60%
LEGN6.47%
AVBP5.42%
BEKE3.79%
CWAN1.93%
CTKB1.74%
MRVL1.01%
Other0.90%

Portfolio allocation by GICS sector

Sectors10
Consumer Cyclical44.08%
Healthcare34.48%
Financial Services11.60%
Technology4.71%
Real Estate3.79%
Consumer Defensive0.95%
Industrials0.17%
Basic Materials0.13%
Utilities0.04%
Unknown0.04%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record35
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used